NL-OMON28874尚未招募不适用
PeRsOnalized treatment fOr patients with pleural eFfusions due to malignant pleural mesothelioma or lung cancer in second or third line. An open label phase II study.
Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with histologically or cytologically proven malignant mesothelioma or non-small cell lung cancer that have a pleural effusion.
- •Age >18 years.
排除标准
- •Active uncontrolled infection, severe cardiac dysfunction or non-correctable bleeding tendency.
- •Any identification of a driver mutation for which a registered treatment is available
研究者
相似试验
尚未招募
2 期
PeRsOnalized treatment fOr patients with pleural eFfusions due to malignant pleural mesothelioma or lung cancer in second or third line. An open label phase II study (Acronym: the PROOF study)mesothelioma and lungcancer10038666NL-OMON40679Antoni van Leeuwenhoek Ziekenhuis80
进行中（未招募）
不适用
Personalized treatment for patients with pleural effusionsEUCTR2013-005621-24-NLStichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis
招募中
不适用
Longitudinal Follow up of Patients With Pleural EffusionPleural Effusion, MalignantPrognosisNCT04670562Seoul National University Bundang Hospital500
已完成
不适用
Management of Parapneumonic Pleurisy Guided by an Early Pleural UltrasoundCommunity-Acquired InfectionsNCT04348734Central Hospital Saint Quentin115
Unknown
不适用
Physical Therapy Intervention in Pleural EffusionPleural EffusionNCT04294485Universidad de Granada30